ctDNA-guided treatment in colorectal cancer

from Illumina Genomics Podcast · host Illumina Genomics Podcast

Jeanne Tie, MD, discusses the DYNAMIC trial and areas of unmet needs for minimal residual disease (MRD) to become the standard of care for patients with colorectal cancer. The DYNAMIC trial showed that a ctDNA-guided approach reduces the use of adjuvant treatment in patients with stage II colon cancer without compromising their clinical outcome. Jeanne Tie is a medical oncologist and professor at Peter MacCallum Cancer Centre.

Episode metadata supplied by the publisher feed · Published Apr 10, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

ctDNA-guided treatment in colorectal cancer

0:00 4:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Illumina Genomics Podcast?

This episode is 4 minutes long.

When was this Illumina Genomics Podcast episode published?

This episode was published on April 10, 2024.

Can I download this Illumina Genomics Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!